Written by: marc

Tagworks@SPIRIT Summer School, Göttingen

9-13 November 2015, SPIRIT Summer School "Multimodal Molecular Imaging: from high resolution in vitro towards in vivo imaging" in Göttingen, Germany. On Thursday 12 November, Tagworks CEO Marc Robillard will instruct on 'Click Chemistry'.
July 1, 2015

Antibody Engineering & Therapeutics, San Diego

7-10 December 2015, Antibody Engineering & Therapeutics, San Diego, CA. More information: ibclifesciences.com/AntibodyEng
July 1, 2015

World ADC Frankfurt 2016

22-24 February 2016, World ADC Frankfurt, Germany. More information: http://worldadc-europe.com
July 1, 2015

World ADC San Diego 2015

19-22 October 2015, World ADC San Diego, CA. More information: http://worldadc-usa.com
July 1, 2015

NanoCity 2015, Amersfoort, the Netherlands

Two-day event on nanotechnology in Amersfoort, the Netherlands. More information: www.nanocity2015.com  
July 1, 2015

Tagworks@ADC Summit London

Tagworks' ceo Marc Robillard will present Tagworks' technology at the ADC Summit in London, May 18-19.
March 10, 2015

Tagworks@Spring symposium of the French Society for Medicinal Chemistry, Paris

Tagworks' ceo Marc Robillard will present Tagworks' technology at the Spring symposium of the French Society for Medicinal Chemistry on 'Bioorthogonal Chemistry contributing to Molecular Therapeutic Innovation' in Paris.
March 10, 2015

Tagworks features in Medicines

The latest edition of Medicines, a Dutch journal on drug development, features Tagworks Pharmaceuticals in the start-up sections. The article by Rik Nijland appeared in Medicines 1, February 2015 (in Dutch) 24_25_med1_startup
March 10, 2015

Paper on improved antibody tag in Molecular Pharmaceutics

Developing an antibody tag with improved pharmacokinetics and stability allowed Tagworks to achieve increased tumor uptake of a radiolabeled pretargeting probe. Even though this adapted tag exhibited a slight loss in reactivity, its use in a antibody (CC49-TCO) conjugate demonstrated a longer clearance half-life, improved tumor accumulation and increased in …
September 5, 2014

Current Opinion in Chemical Biology features Tagworks review

Approaches that use in vivo chemistry to enable non-invasive molecular imaging and therapy are much sought after. Taking the recent achievements in pretargeted radioimmuno-imaging and -therapy in mice as a starting point, the Tagworks team discuss how the application scope of this approach can eventually be extended towards humans. Read …
September 5, 2014

Curious about what we do? Get in touch!

Logo-diap

About    Our Technology   Pipeline    Join us    News    Contact

Contact
T +31 85 800 8550
info@tagworkspharma.com

Address
Tagworks Pharmaceuticals BV
Toernooiveld 1
6525 ED  Nijmegen
The Netherlands

Stay updated

© Tagworks Pharmaceuticals, 2024 | Terms of use | Design by Ape to Zebra